查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1301036

RNA 分析市场规模、份额和趋势分析报告：按产品（试剂盒和试剂、服务、仪器）、按技术（qPCR、微阵列、测序）、按应用、按最终用途、细分趋势，2023-2030 年

RNA Analysis Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Services, Instruments), By Technology (qPCR, Microarray, Sequencing), By Application, By End-use And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

RNA 分析市场增长和趋势

Grand View Research, Inc. 的新报告预测，到 2030 年，全球 RNA 分析市场规模将达到 202.1 亿美元，复合年增长率预计将达到 10.86%，创历史新高

转录组学是后基因组时代的前沿领域之一。 该行业的技术进步源于生命科学中越来越多地应用转录组测序来捕获多腺甘酸化 RNA。 随着下一代高通量测序技术的扩展，转录组分析正在逐步提高我们对基于 RNA 的基因调控网络的理解。 例如，2021 年 7 月，立陶宛的一个研究团队正在开发一种基于液滴的技术，可同时捕获单个细胞内的 mRNA 和 microRNA 并进行测序。

这项研究已获得欧盟 (EU) 提供的 174,000 美元 Horizo□□n 2020 研究补助金。 此外，2022 年 5 月，CD Genomics 宣布了数字 RNA 测序技术，这是一种基于 NGS 的方法，消除了序列依赖性 PCR。 通过这些努力，市场增长预计将很快加速。 核糖核酸转录组分析使研究人员能够分析基因在生物体中的位置以及特定基因的功能模式。 该方法用于评估所有转录本在发育阶段的变化行为，并分析转录本的所有元素，包括信使核糖核酸、非编码核糖核酸和微核糖核酸，以鑑定基因的转录结构。

分析大量基因以了解基因与药物相互作用的需求日益增长，预计将加强转录组学技术在发现和药物开发中的应用。 例如，正在分析 COVID-19 患者的转录组概况，以检查疾病预后和管理。 此外，对个性化药物的需求不断增长预计将在预测期内推动该行业的增长。 2020年4月，Caris Life Sciences宣布已向美国FDA提交MI Transcriptome CDx的上市前申请。 这是一种强大的精密医学检测方法，包含重要的伴随诊断生物标誌物。 同时，转录组研究中缺乏数据管理和有效的生物信息学工具是该行业的主要挑战之一。

高通量技术的发展为全面了解复杂的生物过程提供了独特的机会。 儘管组学数据有相当多的可用性，但将生物数据转化为具有临床价值的知识仍然是主要挑战之一。 这不仅是由于当前的数据处理和集成方法不足，而且是由于现有分析方法的应用不充分。 据报导，由于公司对製药和生物技术研究的投资增加，北美将成为 2021 年创收最高的地区。 由于製造服务成本低廉，亚太地区预计 2022 年至 2030 年復合年增长率最快。

RNA 分析市场报告亮点

  • 到 2022 年，实时 PCR (qPCR) 将占据技术领域的主要市场份额，并且预计在预测期内将延续这一趋势。
  • 由于测序技术的进步和 NGS 技术接受度的提高等因素，转录组测序技术预计在预测期内将实现大幅复合年增长率。
  • 由于转录组研究中耗材的利用率较高，试剂盒和试剂部门在 2022 年的收入份额最高。
  • 传染病和病原体细分市场将在 2022 年占据最大份额，并且预计在预测期内将继续保持这一趋势。
  • 传染病流行的加剧是推动该细分市场增长的主要因素。
  • 随着越来越多的机构和中心利用高通量技术进行高效且有效的核糖核酸分析流程，政府机构和学术中心在最终用户领域占据主导地位。

内容

第一章调查方法及范围

  • 市场细分和范围
  • 市场定义
    • 信息分析
    • 市场形成和数据可视化
    • 验证和发布数据
  • 调查假设
  • 信息获取
    • 初步调查
  • 信息或数据分析
  • 市场形成和验证
  • 市场模式
  • 全球市场：计算复合年增长率
  • 目的

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 竞争格局快照

第三章市场变量、趋势和范围

  • 市场体系展望
    • 母公司市场前景
    • 相关/补充市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场製约因素分析
  • 行业分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19 的影响分析

第四章产品业务分析

  • RNA 分析市场：产品变异分析
  • 设备
    • 2018-2030 年设备市场（百万美元）
  • 试剂盒和试剂
    • 试剂盒和试剂市场，2018-2030 年（百万美元）
    • miRNA 和 siRNA
    • 逆转录□和 RT-PCR
    • RNA提取和纯化
    • RNA干扰
    • 其他
  • 服务
    • 2018-2030 年服务市场（百万美元）

第 5 章技术业务分析

  • RNA分析市场：技术波动分析
  • 实时荧光定量 PCR (qPCR)
    • 实时 PCR (qPCR) 市场，2018-2030 年（百万美元）
  • 微阵列芯片
    • 2018-2030 年微阵列市场（百万美元）
  • 序列
    • 测序市场，2018-2030 年（百万美元）
  • 其他
    • 其他技术市场，2018-2030 年（百万美元）

第六章应用业务分析

  • RNA 分析市场：应用变异分析
  • RNA表达图谱的构建
    • 2018-2030 年构建 RNA 表达图谱的市场（百万美元）
  • 表观遗传学
    • 表观遗传学市场，2018-2030 年（百万美元）
  • 传染病和致病性
    • 传染病和病原体市场，2018-2030 年（百万美元）
  • 选择性 RNA 剪接
    • 替代性 RNA 剪接市场，2018-2030 年（百万美元）
  • RNA结构和分子动力学
    • 2018-2030 年 RNA 结构和分子动力学市场（百万美元）
  • 开发和提供 RNA 疗法
    • 2018-2030 年 RNA 疗法开发和交付市场（百万美元）
  • 其他
    • 其他应用市场，2018-2030 年（百万美元）

第 7 章：最终用途业务分析

  • 政府机构和学术中心
    • 政府和学术中心市场，2018-2030 年（百万美元）
  • 製药和生物技术公司
    • 2018-2030 年製药和生物技术企业市场（百万美元）
  • 医院和诊所
    • 医院和诊所市场，2018-2030 年（百万美元）
  • 委託研究组织 (CRO)
    • 合同研究组织 (CRO) 市场，2018-2030 年（百万美元）

第 8 章区域业务分析

  • 2022 年和 2030 年按地区划分的 RNA 分析市场份额
  • 北美
    • 2018-2030 年北美 RNA 分析市场（百万美元）
    • 美国
    • 加拿大
  • 欧洲
    • 2018-2030 年欧洲 RNA 分析市场（百万美元）
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030 年亚太地区 RNA 分析市场（百万美元）
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 泰国
    • 韩国
  • 拉丁美洲
    • 拉丁美洲 RNA 分析市场，2018-2030 年（百万美元）
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • MEA RNA 分析市场，2018-2030 年（百万美元）
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第 9 章竞争格局

  • 公司分类
  • 战略规划
  • 2022 年公司市场份额分析
  • 公司简介/列表
    • Agilent Technologies, Inc
    • F. Hoffmann-La Roche AG
    • Illumina, Inc.
    • QIAGEN
    • Thermo Fisher Scientific, Inc.
    • Eurofins Scientific
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.
    • Pacific Bioscience of California, Inc.;
    • Affymetrix, Inc.
    • Danaher
    • Promega
Product Code: 978-1-68038-534-2

RNA Analysis Market Growth & Trends

The global RNA analysis market size is expected to reach USD 20.21 billion by 2030, registering a CAGR of 10.86% according to a new report by Grand View Research, Inc.. Transcriptomics is one of the most advanced fields in the post-genomic period. Technological advancements in this industry can be attributed to the increasing applications of transcriptome sequencing in life science for capturing polyadenylated RNA. With the expansion of next-generation high-throughput sequencing technology, the analysis of transcriptomes has been gradually improving the understanding of the regulatory network of RNA-based genes. For instance, in July 2021, the Lithuanian team is developing a droplet-based technique for simultaneous mRNA and microRNA capture and sequencing in a single cell.

The research is backed by the European Union with a USD174,000 Horizon 2020 research grant. Moreover, in May 2022, CD Genomics launched the Digital RNA sequencing technology, which is an NGS-based method that excludes sequence-dependent PCR. Such initiatives are anticipated to accelerate market growth shortly. Ribonucleic acid transcriptome analysis enables the researchers to analyze the position of genes as well as the functional patterns of a specific gene in an organism. The method assists in evaluating every transcript's changing behavior at the development stage and assesses all the elements of a transcript, including messenger ribonucleic acid, non-coding ribonucleic acid, and micro ribonucleic acid, for identifying the transcriptional structure of genes.

The growing need for analyzing a huge number of genes to understand the gene-to-drug interactions is anticipated to enhance the application of transcriptomics technologies in discovery applications and drug development. For instance, transcriptome profiles of COVID-19 patients have been analyzed to examine the disease prognosis and management. Furthermore, increasing demand for personalized medicines is anticipated to fuel the industry growth during the forecast period. In April 2020, Caris Life Sciences announced the submission of Pre-Market Approval applications for MI Transcriptome CDx to the USFDA. It is a powerful precision medicine assay, which contains significant companion diagnostic biomarkers. On the other hand, data management in transcriptomic research and the lack of effective bioinformatics tools are some of the major challenges in the industry.

The evolution of high-throughput technologies has provided invaluable opportunities for generating holistic views of complex biological processes. Despite the considerable availability of omics data, the conversation of biological data into clinically valuable knowledge remains one of the major challenges. It is not only because of insufficient current data processing or integration methods but also for inappropriate application of existing analysis approaches. North America has been reported as the highest revenue-generating region in 2021 owing to increasing investments in pharmaceutical and biotechnology research by corporations. Asia Pacific is projected to register the fastest CAGR from 2022 to 2030 owing to the low-cost manufacturing services.

RNA Analysis Market Report Highlights

  • Real-Time- PCR (qPCR) accounted for the major market share in the technology segment in 2022 and is said to continue the trend during the forecast period owing to the increasing use of PCR for COVID-19 diagnostic across the globe
  • The transcriptome sequencing technology is estimated to register a significant CAGR during the forecast period owing to factors, such as advancements in sequencing technology and growing acceptance of NGS technology
  • The kits and reagents segment accounted for the highest revenue share in 2022 owing to a high utilization rate of consumables during transcriptomic studies
  • The infectious diseases and pathogenesis segment accounted for the largest share in 2022 and is anticipated to have a similar trend during the forecasted period
  • The increasing prevalence of the infectious disease is the major factor driving the segment growth
  • Government institutes & academic centers dominated the end-user segment as the increasing number of institutes and centers leveraged high throughput technologies for the effective and efficient process of ribonucleic acid analysis

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Formulation & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1:
    • 1.9.2. Objective 2:

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Demand for Transcriptomics in Cancer Personalized/Precision Medicine
      • 3.2.1.2. Rising Diagnostic Utility Of Transcriptomics Technologies
      • 3.2.1.3. Advent of Novel Approaches for Understanding Gene Expression at RNA Level
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Higher Cost of Research & Developments
      • 3.2.2.2. High Costs Associated With Analysis Platforms
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. RNA Analysis Market: Product Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.3. Kits & Reagents
    • 4.3.1. Kits & Reagents Market, 2018 - 2030 (USD Million)
    • 4.3.2. miRNA & siRNA
      • 4.3.2.1. miRNA & siRNA Market, 2018 - 2030 (USD Million)
    • 4.3.3. Reverse Transcriptases & RT-PCR
      • 4.3.3.1. Reverse Transcriptases & RT-PCR Market, 2018 - 2030 (USD Million)
    • 4.3.4. RNA Extraction & Purification
      • 4.3.4.1. RNA Extraction & Purification Market, 2018 - 2030 (USD Million)
    • 4.3.5. RNA Interference
      • 4.3.5.1. RNA Interference Market, 2018 - 2030 (USD Million)
    • 4.3.6. Others
      • 4.3.6.1. Other Kits & Reagents Market, 2018 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. RNA Analysis Market: Technology Movement Analysis
  • 5.2. Real Time-PCR (qPCR)
    • 5.2.1. Real Time-PCR (qPCR) Market, 2018 - 2030 (USD Million)
  • 5.3. Microarray
    • 5.3.1. Microarray Market, 2018 - 2030 (USD Million)
  • 5.4. Sequencing
    • 5.4.1. Sequencing Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Other Technologies Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. RNA Analysis Market: Application Movement Analysis
  • 6.2. Construction of RNA Expression Atlas
    • 6.2.1. Construction of RNA Expression Atlas Market, 2018 - 2030 (USD Million)
  • 6.3. Epigenetics
    • 6.3.1. Epigenetics Market, 2018 - 2030 (USD Million)
  • 6.4. Infectious Diseases & Pathogenesis
    • 6.4.1. Infectious Diseases & Pathogenesis Market, 2018 - 2030 (USD Million)
  • 6.5. Alternative RNA Splicing
    • 6.5.1. Alternative RNA Splicing Market, 2018 - 2030 (USD Million)
  • 6.6. RNA Structure & Molecular Dynamics
    • 6.6.1. RNA Structure & Molecular Dynamics Market, 2018 - 2030 (USD Million)
  • 6.7. Development & Delivery of RNA Therapeutics
    • 6.7.1. Development & Delivery of RNA Therapeutics Market, 2018 - 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Other Applications Market, 2018 - 2030 (USD Million)

Chapter 7. End-Use Business Analysis

  • 7.1. Government Institutes & Academic Centers
    • 7.1.1. Government Institutes & Academic Centers Market, 2018 - 2030 (USD Million)
  • 7.2. Pharmaceutical & Biotechnology Companies
    • 7.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 7.3. Hospitals & Clinics
    • 7.3.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 7.4. Contract Research Organizations (CROs)
    • 7.4.1. Contract Research Organizations (CROs) Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. RNA Analysis Market Share By Region, 2022 & 2030
  • 8.2. North America
    • 8.2.1. North America RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Target Disease Prevalence
      • 8.2.2.3. Competitive Scenario
      • 8.2.2.4. U.S. RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Canada RNA Analysis Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. UK RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Germany RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. France RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Italy RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Spain RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Denmark RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Sweden RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Norway RNA Analysis Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Japan RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. China RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. India RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Australia RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.4.6. Thailand
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Thailand RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.4.7. South Korea
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. South Korea RNA Analysis Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Brazil RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Mexico RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Argentina RNA Analysis Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. MEA RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. South Africa RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Saudi Arabia RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. UAE RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Kuwait RNA Analysis Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Share Analysis, 2022
  • 9.4. Company Profiles/Listing
    • 9.4.1. Agilent Technologies, Inc
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. F. Hoffmann-La Roche AG
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Illumina, Inc.
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. QIAGEN
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Thermo Fisher Scientific, Inc.
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Eurofins Scientific
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Merck KGaA
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Bio-Rad Laboratories, Inc.
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Pacific Bioscience of California, Inc.;
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Affymetrix, Inc.
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives
    • 9.4.11. Danaher
      • 9.4.11.1. Overview
      • 9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.11.3. Product Benchmarking
      • 9.4.11.4. Strategic Initiatives
    • 9.4.12. Promega
      • 9.4.12.1. Overview
      • 9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.12.3. Product Benchmarking
      • 9.4.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Global RNA analysis market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global RNA analysis market, by technology, 2018 - 2030 (USD Million)
  • Table 4 Global RNA analysis market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global RNA analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 Global RNA analysis market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 8 North America RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 9 North America RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 10 North America RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 11 U.S. RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 12 U.S. RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 13 U.S. RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 14 U.S. RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 15 Canada RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 16 Canada RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 17 Canada RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 18 Canada RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 19 Europe RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 20 Europe RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 21 Europe RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 22 Europe RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 23 Germany RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 24 Germany RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 25 Germany RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 26 Germany RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 27 U.K. RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 28 U.K. RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 29 U.K. RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 30 U.K. RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 31 France RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 32 France RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 33 France RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 34 France RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 35 Italy RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 36 Italy RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 37 Italy RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 38 Italy RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 39 Spain RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 40 Spain RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 41 Spain RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 42 Spain RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 43 Denmark RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 44 Denmark RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 45 Denmark RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 46 Denmark RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 47 Sweden RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 48 Sweden RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 49 Sweden RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 50 Sweden RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 51 Norway RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 52 Norway RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 53 Norway RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 54 Norway RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 59 China RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 60 China RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 61 China RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 62 China RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 63 Japan RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 64 Japan RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 65 Japan RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 66 Japan RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 67 India RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 68 India RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 69 India RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 70 India RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 71 Australia RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 72 Australia RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 73 Australia RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 74 Australia RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 75 Thailand RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 76 Thailand RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 77 Thailand RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 78 Thailand RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 79 South Korea RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 80 South Korea RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 81 South Korea RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 82 South Korea RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 83 Latin America RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 84 Latin America RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 85 Latin America RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 86 Latin America RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 87 Brazil RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 88 Brazil RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 89 Brazil RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 90 Brazil RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 91 Mexico RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 92 Mexico RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 93 Mexico RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 94 Mexico RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 95 Argentina RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 96 Argentina RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 97 Argentina RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 98 Argentina RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 99 MEA RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 100 MEA RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 101 MEA RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 102 MEA RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 103 South Africa RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 104 South Africa RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 105 South Africa RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 106 South Africa RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 111 UAE RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 112 UAE RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 113 UAE RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 114 UAE RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 116 Kuwait RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 117 Kuwait RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 118 Kuwait RNA analysis market by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 RNA analysis market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 RNA analysis market: Products outlook and key takeaways
  • Fig. 15 RNA analysis market: Product movement analysis
  • Fig. 16 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Kits & reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 miRNA and siRNA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Reverse transcriptase & RT-PCR market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 RNA extraction & purification market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 RNA interference market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Others kits & reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 RNA analysis market: Technology outlook and key takeaways
  • Fig. 25 RNA analysis market: Technology movement analysis
  • Fig. 26 Real time-PCR (qPCR) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Microarray market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Other technologies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 RNA analysis market: Application outlook and key takeaways
  • Fig. 31 RNA analysis Market: Application movement analysis
  • Fig. 32 Construction of RNA expression atlas market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Epigenetics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Infectious diseases and pathogenesis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Alternative RNA splicing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 RNA structure and molecular dynamics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Development and delivery of RNA therapeutics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Others applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 RNA analysis market: End-use outlook and key takeaways
  • Fig. 40 RNA analysis market: End-use movement analysis
  • Fig. 41 Government institutes & academic centers estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Pharmaceutical & biotechnology companies estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Hospitals & clinics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Contract Research Organizations (CROs) estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 RNA analysis market: Regional outlook and key takeaways
  • Fig. 46 RNA analysis market: Regional movement analysis
  • Fig. 47 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)